Shaping the Future of Health Tech.
arterioscope’s mission is to revolutionize the way we understand the diagnosis and treatment of cardiovascular diseases, one of the biggest health challenges in our society.
Transforming Cardiovascular Health through AI-Powered Diagnostics
The core of our patented technology is an advanced AI algorithm, capable of
interpreting measurement data from ECG and PPG with 97% accuracy.
Heart-Failure
Digital Twin Simulation
Research & Dev
Cardiac Screening
arterioscope.AI-ECG is an efficient and
powerful tool for primary care
physicians and hospitals to screen for
cardiac dysfunction in at-risk patients
non-invasively and in real-time by
analyzing cardiac biomarkers from ECG
(Electrocardiogram) data using
advanced machine learning.
arterioscope offers cutting-edge digital twin blood flow simulation technology for research and development purposes. Our advanced simulations provide precise and detailed insights, empowering researchers and developers to innovate and optimize cardiovascular treatments effectively.
Our Use-Cases
Diabetes Complications
arterioscope is dedicated to helping millions of diabetes patients monitor their cardiovascular risks. We provide highly accessible, non-invasive diagnostic tools that enable early detection and management of complications, ultimately improving patient outcomes and quality of life.
Risk Monitoring
Our Science & Publications
Bayesian uncertainty quantification with multi-fidelity data and gaussian processes for impedance cardiography of aortic dissection
Dec., 31th, 2019
May., 5th, 2022
Feb., 1st, 2023
Feb., 1st, 2024
Learn about the technology of arterioscope from 50+ peer reviewed publications
All Publications
Our Customer Segments
Join arterioscope in a fast growing market for cardiovascular related healthcare technologies.
OEMs
Healthcare
Pharmaceutical
“At arterioscope, we are committed to revolutionizing cardiovascular health by providing innovative, non-invasive diagnostic solutions”
Meet the Founders
- Co-Founder & CSO
- DI Dr. Sascha Ranftl
- Co-Founder & CTO
- Dr. Vahid Badeli
- Co-Founder & CEO
- Hermann Moser, MA MA
Our valued Advisory Board
- Dr. Ghazaleh Gouya
- Werner Koele, MSc
- Prof. Dr. Gerhard Holzapfel
- Prof. Dr. Julia Mader
Prof. Dr. Alice Reinbacher-
- Köstinger
- Dr. Tilmann Kluge
- Dr. Markus Wuchse
- DI Fritz Bruner
MD Cardiology
- CEO Gouya Insights
Co-Founder & CEO
- Steadysense GmbH
Head Institute of Biomechanics,
- Graz University of Technology
MD Diabetology,
- Medical University of Graz
Professor Institute IGTE,
Graz University of Technology
- Head of BU Medical Signal Analysis, AIT GmbH
- Independent Med-Tech Consultant
- Former Top Management, Regional Health Insurance Fund Styria
Our Company Story
arterioscope is a spin-off from the University of Technology in Graz, Austria. Since its inception in 2018 as a strategic lead project, our technology has evolved through the dedication of great scientists and entrepreneurs.
- By 2024 we are proud to offer a technology to revolutionize the understanding of diagnostics and treatment for cardiovascular diseases, to make a difference for the industry and help millions of patients out there.
arterioscope.SIM
Aorta Bloodflow Simulation
http://dx.doi.org/10.3389/fbioe.2022.1033450
0.0 s
arterioscope FlexCo
Sandgasse 36 / 4th Floor
8010 Graz
Austria
Company Registration Number
FN 646824m
Mailing
hello@arterioscope.com
Get in touch
Please send us a message via Email to discuss partnership opportunities.
We are currently also raising capital from new investors.